Corticosteroid Compositions
Patent No. EP3574914 (titled "Corticosteroid Compositions") was filed by Meritage Pharma on Nov 12, 2008. The application was issued on Dec 29, 2021.
Patent Summary
A stable oral pharmaceutical composition for treating esophageal inflammation, comprising a corticosteroid suspended in an aqueous medium, with a viscosity that enables topical delivery to the esophagus. The composition maintains uniformity after storage and agitation, and can be administered in single or multiple doses.
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP3574914
- Application Number
- EP19165329A
- Filing Date
- Nov 12, 2008
- Status
- Revoked
- Jun 2, 2023
- Publication Date
- Dec 29, 2021
- External Links
- Slate, Register , Google Patents